Ariane L Herrick

Summary

Affiliation: University of Manchester
Country: UK

Publications

  1. ncbi Development of agents for the treatment of systemic sclerosis
    A L Herrick
    Rheumatic Diseases Centre, Hope Hospital, University of Manchester Medical School, Manchester, M13 9PT, UK
    Expert Opin Investig Drugs 10:1255-64. 2001
  2. ncbi A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis
    A L Herrick
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Clin Exp Rheumatol 18:349-56. 2000
  3. ncbi Vascular function in systemic sclerosis
    A L Herrick
    University of Manchester, Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Curr Opin Rheumatol 12:527-33. 2000
  4. ncbi Acute intermittent porphyria
    Ariane L Herrick
    University of Manchester, Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Best Pract Res Clin Gastroenterol 19:235-49. 2005
  5. ncbi Pathogenesis of Raynaud's phenomenon
    A L Herrick
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Rheumatology (Oxford) 44:587-96. 2005
  6. ncbi Treatment of Raynaud's phenomenon: new insights and developments
    Ariane L Herrick
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Curr Rheumatol Rep 5:168-74. 2003
  7. ncbi Genetic epidemiology: systemic sclerosis
    Ariane L Herrick
    Arthritis Research Campaign Epidemiology Unit, University of Manchester, UK
    Arthritis Res 4:165-8. 2002
  8. ncbi Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders
    Andrea K Murray
    School of Translational Medicine, University of Manchester, Salford Royal NHS Foundation Trust, Salford, UK
    Arthritis Rheum 61:1103-11. 2009
  9. ncbi The influence of measurement location on reliability of quantitative nailfold videocapillaroscopy in patients with SSc
    Andrea K Murray
    Clinical Sciences Building, University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheumatology (Oxford) 51:1323-30. 2012
  10. ncbi Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia
    Ariane L Herrick
    The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheumatology (Oxford) 49:1776-82. 2010

Collaborators

Detail Information

Publications53

  1. ncbi Development of agents for the treatment of systemic sclerosis
    A L Herrick
    Rheumatic Diseases Centre, Hope Hospital, University of Manchester Medical School, Manchester, M13 9PT, UK
    Expert Opin Investig Drugs 10:1255-64. 2001
    ..Conversely, it is to be hoped that in the future, drugs shown to be effective in SSc might prove beneficial for other fibrotic diseases...
  2. ncbi A double-blind placebo-controlled trial of antioxidant therapy in limited cutaneous systemic sclerosis
    A L Herrick
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Clin Exp Rheumatol 18:349-56. 2000
    ..To evaluate the effects of a combination of micronutrient antioxidants (selenium, beta-carotene, vitamin C, vitamin E and methionine) with allopurinol in patients with limited cutaneous systemic sclerosis (SSc)...
  3. ncbi Vascular function in systemic sclerosis
    A L Herrick
    University of Manchester, Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Curr Opin Rheumatol 12:527-33. 2000
    ....
  4. ncbi Acute intermittent porphyria
    Ariane L Herrick
    University of Manchester, Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Best Pract Res Clin Gastroenterol 19:235-49. 2005
    ..Finally we discuss management, including family screening, avoidance of triggering factors, analgesia, maintenance of a high calorie intake, and administration of haem derivatives...
  5. ncbi Pathogenesis of Raynaud's phenomenon
    A L Herrick
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Rheumatology (Oxford) 44:587-96. 2005
    ..As our understanding of the pathophysiology of Raynaud's phenomenon increases, so do our possibilities for identifying effective treatments...
  6. ncbi Treatment of Raynaud's phenomenon: new insights and developments
    Ariane L Herrick
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Curr Rheumatol Rep 5:168-74. 2003
    ..The necessity of prompt assessment and treatment of acute digital ischemia, which is a medical emergency, is highlighted...
  7. ncbi Genetic epidemiology: systemic sclerosis
    Ariane L Herrick
    Arthritis Research Campaign Epidemiology Unit, University of Manchester, UK
    Arthritis Res 4:165-8. 2002
    ..Recent advances in genetic methodologies should further our understanding of this complex disease process...
  8. ncbi Noninvasive imaging techniques in the assessment of scleroderma spectrum disorders
    Andrea K Murray
    School of Translational Medicine, University of Manchester, Salford Royal NHS Foundation Trust, Salford, UK
    Arthritis Rheum 61:1103-11. 2009
    ....
  9. ncbi The influence of measurement location on reliability of quantitative nailfold videocapillaroscopy in patients with SSc
    Andrea K Murray
    Clinical Sciences Building, University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheumatology (Oxford) 51:1323-30. 2012
    ..Conversely a wide-field, high-magnification system that allows visualization of the whole nail bed offers a highly reproducible approach for quantitative assessment and therefore has potential as an outcome measure...
  10. ncbi Nail-fold capillary abnormalities are associated with anti-centromere antibody and severity of digital ischaemia
    Ariane L Herrick
    The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheumatology (Oxford) 49:1776-82. 2010
    ..v. vasodilators, debridements or amputations), (ii) a positive ACA, (iii) clinically evident calcinosis, (iv) pulmonary arterial hypertension and (v) telangiectases...
  11. ncbi Preliminary clinical evaluation of semi-automated nailfold capillaroscopy in the assessment of patients with Raynaud's phenomenon
    Andrea K Murray
    School of Translational Medicine, The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK
    Microcirculation 18:440-7. 2011
    ..Our aim was to compare semi-automatic feature measurement from newly developed software with manual measurements, and determine the degree to which semi-automated data allows disease group classification...
  12. ncbi Reliability of dermoscopy in the assessment of patients with Raynaud's phenomenon
    Tonia L Moore
    Salford Royal NHS Foundation Trust, Salford M6 8HD, UK
    Rheumatology (Oxford) 49:542-7. 2010
    ..Good reliability is a necessary prerequisite for a test to be a valid clinical or research tool...
  13. ncbi Clinical features of childhood localized scleroderma in an incidence cohort
    Ariane L Herrick
    Arthritis Research UK Epidemiology Unit, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    Rheumatology (Oxford) 50:1865-8. 2011
    ..Our aim was to describe clinical features and pattern of care in children with localized scleroderma presenting to secondary care during a 25-month incidence study...
  14. ncbi Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy
    Louise K Mercer
    ARC Epidemiology Unit, University of Manchester, Stopford Building, Oxford Road, Manchester M13 9PT, UK
    Rheumatology (Oxford) 49:1699-705. 2010
    ....
  15. ncbi Contemporary management of Raynaud's phenomenon and digital ischaemic complications
    Ariane L Herrick
    The University of Manchester, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Salford, UK
    Curr Opin Rheumatol 23:555-61. 2011
    ..New approaches to therapy are being driven by increased understanding of pathophysiology and by increased international networking of clinicians and scientists, facilitating clinical trials...
  16. ncbi Expression of advanced glycation end products and their receptor in skin from patients with systemic sclerosis with and without calcinosis
    Christine A Davies
    Tissue Injury and Repair Research Group, Research School of Clinical and Laboratory Sciences, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK
    Rheumatology (Oxford) 48:876-82. 2009
    ....
  17. ncbi Therapy: A local approach to Raynaud phenomenon
    Ariane L Herrick
    University of Manchester and Salford Royal Hospital, Salford, Manchester, UK
    Nat Rev Rheumatol 5:246-7. 2009
    ..Topical, or transdermal, treatments that increase digital blood flow without systemic adverse effects are, therefore, an attractive option. A novel topical nitroglycerin formulation has shown promise in treating Raynaud attacks...
  18. ncbi Digital iontophoresis of vasoactive substances as measured by laser Doppler imaging--a non-invasive technique by which to measure microvascular dysfunction in Raynaud's phenomenon
    M E Anderson
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Rheumatology (Oxford) 43:986-91. 2004
    ..If reproducibility is confirmed to be satisfactory, then these techniques could be used to examine disease progression over time and responsiveness to vasoactive treatment, thus facilitating clinical trials...
  19. ncbi Systemic sclerosis: an update for clinicians
    Ariane L Herrick
    Rheumatic Diseases Centre, Clinical Sciences Building, University of Manchester, Salford Royal NHS Foundation Trust, Salford M6 8HD
    Br J Hosp Med (Lond) 69:464-70. 2008
    ..This review will discuss diagnosis, subtyping, and the major clinical features and their management...
  20. ncbi Comparison of thermography and laser Doppler imaging in the assessment of Raynaud's phenomenon
    Stuart Clark
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, M6 8HD, Salford, UK
    Microvasc Res 66:73-6. 2003
    ..Therefore one technique cannot substitute for another...
  21. ncbi Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland
    Ariane L Herrick
    University of Manchester, Manchester, UK, and Salford Royal Hospital, Salford, UK
    Arthritis Care Res (Hoboken) 62:213-8. 2010
    ..Our aim was to ascertain the incidence of childhood scleroderma in its different forms in the UK and Ireland, and to describe the age, sex, and ethnicity of the cases...
  22. ncbi Possible therapeutic use of vasodilator iontophoresis
    Andrea K Murray
    Department of Physics and Astronomy, Laser Photonics Group, University of Manchester, Oxford Road, Manchester, M13 9PL, UK
    Microvasc Res 69:89-94. 2005
    ..The current treatment of choice for scleroderma-related critical digital ischaemia and/or ulceration is intravenous prostanoid therapy, necessitating hospitalisation. However, iloprost is often poorly tolerated and may be ineffective...
  23. ncbi Vascular imaging
    Ariane L Herrick
    University of Manchester, Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Best Pract Res Clin Rheumatol 18:957-79. 2004
    ..For each of these, the method(s) and then the clinical and research applications are discussed. Laser Doppler, a research technique, is also described...
  24. ncbi Comparison of red and green laser doppler imaging of blood flow
    Andrea K Murray
    Laser Photonics Group, University of Manchester, Manchester M13 9PL, United Kingdom
    Lasers Surg Med 35:191-200. 2004
    ..Laser Doppler imaging (LDI) of perfusion has been performed with a novel green wavelength (532 nm) for comparison with a HeNe laser (633 nm), the aim being validation of the green laser wavelength as a research tool...
  25. ncbi Laser Doppler imaging: a developing technique for application in the rheumatic diseases
    A K Murray
    University of Manchester, Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Rheumatology (Oxford) 43:1210-8. 2004
  26. ncbi Nailfold video capillaroscopy in psoriasis
    M Bhushan
    Dermatology Centre and Centre for Rheumatic Diseases, University of Manchester, Hope Hospital, Salford, Manchester M6 8HD, U K
    Br J Dermatol 142:1171-6. 2000
    ..However, in contrast to previous studies, we found no specific pattern of a morphological nature of nailfold capillaries in patients with psoriasis with or without nail changes, when compared with normal controls...
  27. ncbi Computerized nailfold video capillaroscopy--a new tool for assessment of Raynaud's phenomenon
    Marina E Anderson
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    J Rheumatol 32:841-8. 2005
    ....
  28. ncbi Digital vascular response to topical glyceryl trinitrate, as measured by laser Doppler imaging, in primary Raynaud's phenomenon and systemic sclerosis
    M E Anderson
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Rheumatology (Oxford) 41:324-8. 2002
    ..As well as demonstrating the effectiveness of topical GTN in patients with PRP and LCSSc, this study illustrates the ability of laser Doppler imaging to quantify local vasodilatory effects...
  29. ncbi Vasodilator iontophoresis a possible new therapy for digital ischaemia in systemic sclerosis?
    A K Murray
    Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Rheumatology (Oxford) 47:76-9. 2008
    ..This study investigated whether whole finger vasodilator iontophoresis increases digital blood flow in patients with systemic sclerosis (SSc): If so, this might indicate a novel approach to therapy...
  30. ncbi Lack of agreement between rheumatologists in defining digital ulceration in systemic sclerosis
    Ariane L Herrick
    University of Manchester, Manchester, UK, and Salford Royal National Health Service Foundation Trust, Salford, UK
    Arthritis Rheum 60:878-82. 2009
    ..To test the intra- and interobserver variability, among clinicians with an interest in systemic sclerosis (SSc), in defining digital ulcers...
  31. ncbi Occurrence of Raynaud's phenomenon in children ages 12-15 years: prevalence and association with other common symptoms
    Gareth T Jones
    University of Manchester, Manchester, UK
    Arthritis Rheum 48:3518-21. 2003
    ..There were no associations with psychosocial variables. CONCLUSION: RP is frequent in children ages 12-15 years. Unlike other common childhood symptoms, RP showed no association with psychosocial factors in this study...
  32. ncbi Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis
    B J Harrison
    Department of Rheumatology, North Manchester General Hospital and ARC Epidemiology Unit, University of Manchester, UK
    Ann Rheum Dis 61:1007-11. 2002
    ..Bone mineral density (BMD) can now be measured accurately using dual energy x ray absorptiometry (DEXA). Recently, DEXA has been used to measure periarticular BMD at predefined regions of interest (ROIs) around the joints...
  33. ncbi Dual wavelength (532 and 633 nm) laser Doppler imaging of plaque psoriasis
    A K Murray
    Laser Photonics Group, Department of Physics and Astronomy, University of Manchester, Manchester M13 9PL, UK
    Br J Dermatol 152:1182-6. 2005
    ..Increased blood flow occurs in plaques of psoriasis, and an increase in blood flow has been shown to occur in uninvolved skin adjacent to the active edge...
  34. ncbi Abnormal microvascular response is localized to the digits in patients with systemic sclerosis
    A K Murray
    Hope Hospital, Salford, UK
    Arthritis Rheum 54:1952-60. 2006
    ....
  35. ncbi Acro-osteolysis in systemic sclerosis is associated with digital ischaemia and severe calcinosis
    Emma M Johnstone
    Clinical Sciences Building, Salford Royal Hospital, Salford M6 8HD, UK
    Rheumatology (Oxford) 51:2234-8. 2012
    ..The potential association with severe calcinosis merits further study. Prospective studies are required to investigate acro-osteolysis as a marker of digital vascular disease progression and of treatment response...
  36. ncbi Systemic sclerosis: patients' perceptions of their condition
    Helen L Richards
    Department of Behavioural Medicine, Hope Hospital, Salford, United Kingdom
    Arthritis Rheum 49:689-96. 2003
    ..To examine patients' beliefs about systemic sclerosis (SSc) and to investigate the relationship between these beliefs, symptom report, and clinical and demographic variables...
  37. ncbi Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
    Ariane L Herrick
    University of Manchester, Manchester Academic Health Science Centre, Salford Royal Hospital, Salford, UK
    Arthritis Rheum 63:775-82. 2011
    ..To examine the effect of sildenafil in patients with Raynaud's phenomenon (RP) secondary to limited cutaneous systemic sclerosis (lcSSc)...
  38. ncbi Cigarette smoking as a significant risk factor for digital vascular disease in patients with systemic sclerosis
    Beverley J Harrison
    North Manchester General Hospital and ARC Epidemiology Unit, Manchester, UK
    Arthritis Rheum 46:3312-6. 2002
    ..Cigarette smoking is an important risk factor for vascular disease in the general population. We investigated the influence of cigarette smoking on digital ischemia in patients with SSc...
  39. ncbi The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis
    Christine Ann Davies
    Division of Laboratory and Regenerative Medicine, University of Manchester, UK
    Hum Pathol 37:190-7. 2006
    ..Increased GLUT-1 expression in lcSSc/cal and dcSSc indicates that hypoxia is an associated factor...
  40. ncbi An investigation into the blood-flow characteristics of telangiectatic skin lesions in systemic sclerosis using dual-wavelength laser Doppler imaging
    A K Murray
    Rheumatic Diseases Centre, Hope Hospital, University of Manchester, Manchester, UK
    Clin Exp Dermatol 34:618-20. 2009
    ..Dual-wavelength LDI may help predict treatment response...
  41. ncbi Home parenteral nutrition--an effective and safe long-term therapy for systemic sclerosis-related intestinal failure
    M Brown
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, Manchester, UK
    Rheumatology (Oxford) 47:176-9. 2008
    ....
  42. ncbi Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis
    C A Davies
    Rheumatic Diseases Centre, Clinical Sciences Building, Hope Hospital, Eccles Old Road, Salford M6 8HD, UK
    Rheumatology (Oxford) 45:1349-55. 2006
    ....
  43. ncbi Antibodies against oxidized low-density lipoproteins in systemic sclerosis
    A L Herrick
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Rheumatology (Oxford) 40:401-5. 2001
    ..Prospective longitudinal studies are required to investigate whether anti-oxidized LDL antibodies may be a marker of vascular damage in SSC...
  44. ncbi Foot problems in patients with systemic sclerosis
    H Sari-Kouzel
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Rheumatology (Oxford) 40:410-3. 2001
    ..Care of the feet is therefore an important part of the management of SSC...
  45. ncbi Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody
    M C Wan
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    Rheumatology (Oxford) 40:1102-5. 2001
    ..04 (95% CI -0.01 to +0.09). CONCLUSIONS: The severity of large vessel macrovascular disease, as assessed by ABPI, is not dependent on disease subtype. Anticentromere antibody may be weakly associated with a reduction in ABPI...
  46. ncbi Pilot study of dual-wavelength (532 and 633 nm) laser Doppler imaging and infrared thermography of morphoea
    T L Moore
    Rheumatic Diseases Centre, University of Manchester, Salford Royal NHS Foundation Trust, Salford, UK
    Br J Dermatol 160:864-7. 2009
    ..Little is known about the pathophysiology of localized scleroderma (skin fibrosis, also termed 'morphoea'), although it is likely that microvascular dysfunction is a contributing factor...
  47. ncbi Keloidal scleroderma
    T C Ling
    The Dermatology Centre, Hope Hospital, Manchester, UK
    Clin Exp Dermatol 28:171-3. 2003
    ..The nodules failed to respond to therapy with topical steroid, calcipotriol, or extended photochemotherapy. This is a rare, disfiguring variant of scleroderma, unresponsive to treatment, and poorly understood...
  48. ncbi Seventeen-point dermal ultrasound scoring system--a reliable measure of skin thickness in patients with systemic sclerosis
    T L Moore
    University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford, UK
    Rheumatology (Oxford) 42:1559-63. 2003
    ..92 for maximum thickness). CONCLUSION: Our results suggest that the 17-point dermal ultrasound scoring system is extremely reliable and may therefore be a useful measure of outcome, including in clinical trials...
  49. ncbi A pilot study of acetic acid iontophoresis and ultrasound in the treatment of systemic sclerosis-related calcinosis
    S Shetty
    University of Manchester Rheumatic Diseases Centre, Salford, Leeds, UK
    Rheumatology (Oxford) 44:536-8. 2005
    ..However, there may have been some radiographic improvement. Given that there is currently no effective treatment for SSc-related calcinosis a larger study incorporating higher 'doses' of iontophoresis is indicated...
  50. ncbi Polymorphisms in COL15 gene are not associated with systemic sclerosis
    Sudeep P Pushpakom
    National Genetics Reference Laboratory, Department of Medical Genetics, St Mary s Hospital, Hathersage Road, Manchester M13 0JH, UK
    J Rheumatol 35:251-3. 2008
    ..We undertook an association study to explore the role of COL15 single-nucleotide polymorphisms (SNP) in SSc disease development...
  51. ncbi A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
    Rachel K Hoyles
    Royal Brompton Hospital, Imperial College, London, UK
    Arthritis Rheum 54:3962-70. 2006
    ..Therapy was well tolerated with no increase in serious adverse events...
  52. ncbi Development of a provisional core set of response measures for clinical trials of systemic sclerosis
    D Khanna
    Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, California 90095, USA
    Ann Rheum Dis 67:703-9. 2008
    ..To develop a provisional core set of response measures for clinical trials of systemic sclerosis (SSc)...
  53. ncbi Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome
    Gillian Rice
    Leeds Institute of Molecular Medicine, St James s University Hospital, Leeds, LS9 7TF, UK
    Am J Hum Genet 80:811-5. 2007
    ..Additionally, we describe a de novo heterozygous mutation, affecting a critical catalytic residue in TREX1, that results in typical Aicardi-Goutieres syndrome...